This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Feng, M. Articles by Eisbruch, A. Search for Related Content PubMed PubMed Citation Articles by Feng, M. Articles by Eisbruch, A. Social Bookmarking                            What's this?

Future Issues in Highly Conformal Radiotherapy for Head and Neck Cancer

Mary Feng, Avraham Eisbruch

From the Department of Radiation Oncology, University of Michigan, Ann Arbor, MI

Address reprint requests to Avraham Eisbruch, MD, University of Michigan Hospital, Department of Radiation Oncology, 1500 E Medical Center Dr, UH B2C490 Box 0010, Ann Arbor, MI 48109; e-mail: eisbruch{at}med.umich.edu

Improving the conformity of the radiation dose to targets in the head and neck promises reduced toxicity and, in some cases, potentially improved local-regional tumor control. Intensity-modulated radiotherapy (IMRT) is a method that allows highly conformal delivery of radiotherapy. In recent years, its use has spread rapidly in both academic and community radiation oncology facilities. The use of IMRT has raised multiple issues related to target definition, optimal treatment delivery methods, and the need to account for anatomic changes occurring during therapy. Some of these issues are reviewed in this article.

Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				J. S. Ross, E. A. Slodkowska, W. F. Symmans, L. Pusztai, P. M. Ravdin, and G. N. Hortobagyi The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti-HER-2 Therapy and Personalized Medicine Oncologist, April 1, 2009; 14(4): 320 - 368. [Abstract] [Full Text] [PDF]

				V. Gregoire, W. De Neve, A. Eisbruch, N. Lee, D. Van den Weyngaert, and D. Van Gestel Intensity-Modulated Radiation Therapy for Head and Neck Carcinoma Oncologist, May 1, 2007; 12(5): 555 - 564. [Abstract] [Full Text] [PDF]

				T. S. Lawrence, N. J. Petrelli, B. D. Li, and J. M. Galvin Think Globally, Act Locally J. Clin. Oncol., March 10, 2007; 25(8): 921 - 923. [Full Text] [PDF]